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Background: Japanese encephalitis virus (JEV) is one of the major causative agents of viral encephalitis in East Asia,
Southeast Asia and Australia. However, no clinical JEV strain has yet been isolated from JE patients in Chongqing,
China. In this study, we report the genomic analysis of a new JEV strain, CQ11-66, isolated from a pediatric patient
in Chongqing, China.
Findings: Virus isolation was carried out in BHK-21 cells. Nested PCR was used to detect and isolate the JEV strain,
and computer analysis of phylogenetic relationships, nucleic acid homology studies and deduction of the amino
acid sequence were conducted using ClustalX (1.8) and Mega5 software. The JEV strain CQ11-66 was isolated from
patient cerebrospinal fluid. The sequenced genome of CQ11-66 was 10,863 nucleotides in length, whereas other
strains, such as SX09S-01, contain 10,965 nucleotides. Sequence comparison of the CQ11-66 polyprotein open
reading frame (ORF) with those of 21 other JEV strains revealed that the nucleotide sequence divergence ranged
from 1.68% to 18.46%. Sequence analysis of the full-length CQ11-66 E gene sequence with those of 30 other JEV
isolates also identified nucleotide divergence, ranging from 1.69% to 18.74%. Phylogenetic analyses indicated that
the CQ11-66 strain belonged to genotype III.
Conclusions: JEV genotype III still circulates in Chongqing and it is therefore important for active surveillance of
JEV genotype III to be conducted in the pediatric population.
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Japanese encephalitis virus (JEV) is the most import-
ant causes of epidemic encephalitis in Southeast Asia
and Western Pacific regions, with an estimated
35,000 to 50,000 cases each year, and approximately
1-3 of every 1000 JEV infections resulting in severe
disease [1]. JEV is a small, enveloped virus with a
single-stranded, positive-sense RNA genome of ap-
proximately 11,000 nt. Its ORF is translated into a
large polyprotein that includes three structural pro-
teins (C, prM and E) and seven non-structural pro-
teins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5)
[2]. Since the first JEV isolate was reported in 1949,* Correspondence: boybvip@126.com
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reproduction in any medium, provided the orJE epidemics have occurred in China, and Chongqing
is listed as the region of highest incidence. However,
no clinical JEV strain has been isolated from human
cerebrospinal fluid (CSF), serum or brain tissue of
fatal cases in Chongqing; thus, the molecular charac-
teristics and genetic diversity of clinical JEV strains
remain unknown.
In this study, acute serum and CSF specimens were
collected from patients who were clinically diagnosed
with Japanese encephalitis (JE) during July to October
in 2011 and hospitalized in the Children’s Hospital of
Chongqing Medical University. Serum specimens were
diluted in minimal essential medium at a ratio of 1 to
5, pretreated with 100 U ml-1 penicillin and strepto-
mycin and placed for at least four hours at 4°C. CSF
specimens were incubated directly. A monolayer of
BHK-21 cells was grown to 90% confluence and incu-
bated with either CSF or diluted serum at 37°C. OnceThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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viruses were harvested from the culture medium by
centrifugation at 10,000 rpm for 10 min. Viral RNA
was extracted from the supernatant (140 μL) of
infected BHK-21 cells cultures using the QIAampW
Viral RNA kit (QIAGEN; USA). RNA was reverse-
transcribed using a random primer and amplified with
a Go TagW Hot Start Polymerase kit (Promega; USA).
The full-length genome was amplified by polymerase
chain reaction (PCR) with TaKaRa LA Taq polymerase
(TaKaRa; China) using seven pairs of primers
(Table 1). The PCR reaction conditions were as fol-
lows: 3 min of cDNA denaturation at 94°C, followed
by 30 cycles of 94°C denaturation for 30 sec, 55°C pri-
mer annealing for 30 sec, and 72°C primer extension
for 1 min. Amplified products were examined by agar-
ose gel electrophoresis (1%), purified with a Takara
MiniBEST Agarose Gel DNA Extraction Kit Ver 3.0
(TaKaRa; China) and sent to TaKaRa for commercial
sequencing. The full-length genome of the strains was
compiled using the SeqMan program in the Lasergene
software package (DNASTAR). The percentage simi-
larities between aligned nucleotide or amino acid se-
quences were calculated using MEGA 5 software.
Phylogenetic analysis was performed by the neighbor-
joining (NJ) method using MEGA5 software. For the
previously published JEV strain sequences, the host
background, year of isolation, geographic origin and
GenBank accession number are listed in Table 2. Mul-
tiple sequence alignments and the NJ tree were gene-
rated by ClustalX (1.8). The genomic sequence of 21
strains and the E gene sequence of 30 strains were
employed in the generation of the phylogenetic trees.
The bootstrap probabilities of each node were calcu-
lated using 100 replicates.Table 1 Primers for nucleic acid amplification assays














PrimerR7 TCTTCCTCACCACCAGCTACAT 22In total, only one cell culture incubated with a patient
CSF sample, named CQ11-66, tested positive by PCR, and
none of the cell cultures incubated with patient serum
samples tested positive. The genome sequence of CQ11-66
was 10,863 nucleotides in length, with an open reading
frame (ORF) (GenBank: KC183732) of 10,296 nt coding
for a polyprotein. When comparing its ORF with that of 21
other JEV strains isolated from different geographic regions
or periods, high levels of similarity were observed, with nu-
cleotide divergence ranging from 1.68% to 18.46%, and
amino acid divergence ranging from 0.32% to 4.89%. A
comparison of the CQ11-66 polyprotein ORF with that of
SA14-14-2, the attenuated JEV vaccine strain currently
widely used in China, discovered a total of 201 nucleotide
differences (1.96%) and 42 amino acid differences (1.23%).
The nucleotide and amino acid sequences of the CQ11-66
strain E region were compared with those of other isolates
available in GenBank. This analysis revealed that nucleotide
divergence ranged from 1.62% to 18.74%, while deduced
amino acid divergence ranged from 1.01% to 5.13%. Among
these amino acid mutations, the E408 (Arg to Lys) variation
was unique to CQ11-661. A comparison of the CQ11-66
strain E gene with that of SA14-14-2 also indicated 36 nu-
cleotide changes, resulting in 15 amino acid changes: E76
(Thr to Met), E107 (Phe to Leu), E138 (Lys to Glu), E176
(Val to Thr), E177 (Ala to Thr), E209 (Lys to Arg), E227 (Ser
to Pro), E244 (Gly to Glu), E264 (His to Gln), E279 (Met to
Lys), E306 (Glu to Gly), E315 (Val to Ala), E408 (Arg to Lys),
E416 (Asp to Gly) and E439 (Asp to Gly). On the basis of
the ORF gene sequences of 22 JEV isolates and the E gene
sequences of 31 JEV isolates, phylogenetic trees were
constructed (shown in Figures 1 and 2). Both phylogenetic
trees provided similar topology, and the analysis indicated
that the CQ11-66 strain belonged to genotype III.
On the basis of 240 nucleotide of the C/prM gene, JEV
strains were divided into five genotypes two decades ago
[3,4]. However, the functional significance of the prM gen-
etic variations remains to be established, and genetic rela-
tionships based on short sequences (<300 nt) should be
required to take into account the biological significance
and may be considered with caution [5,6]. Subsequently,
the full-length E gene of JEV and its deduced protein se-
quence have been used as reliable phylogenetic markers,
given that the E protein plays an important role in the
JEV life cycle [7]. In China, many JEV strains belonging to
genotype I and genotype III have been reported, and it
was suggested by surveillance data that genotype I strains
have been gradually replacing genotype III as the domin-
ant strains in Asia. Due to limited sequence information
regarding JEV isolates in Chongqing, the dominant geno-
type in one of the high-incidence regions in China remains
unclear. In this study, phylogenetic analyses employing the
ORF and E gene sequence of the CQ11-66 strain indicated
it belonged to genotype III.
Table 2 Bankground of Japanese encephalitis virus strains used in this study
Strain Source Genotype Geographical location Year GenBank accession no./reference
ORF E gene
Beijing-1 Human III China 1948 L48961 L48961
CH1392 Mosquito III Taiwan 1990 AF254452 U44960.1
FU Human II Australia 1995 AF217620 L43565.1
GP78 Human III India 1978 AF075723 AF075723
SA14-14-2 Vaccin strain III China 1954 AF315119.1 AF315119.1
JaGAr01 Mosquito III Japan 1959 AF069076 AF069076
WTP Mosquito II Malaysia 1970 HQ223286 U70421
K94P05 Mosquito I Korea 1994 AF04555 U34929
JKT5441 Mosquito II Indonesia 1981 AF045551 U34929
JKT6468 Mosquito IV Indonesia 1981 AY184212 U70407
Ishikawa Mosquito I Japan 1998 AB051292 AB051292
Ling Human III Taiwan 1965 L78128 L78128
RP-9 Mosquito III Taiwan 1985 AF014161 AF014161
47 Human III China 1950s AY243827 AY243827
SA14 Mosquito III China 1960 U14163 AY243850
K87P39 Mosquito III Korea 1987 AY585243 AY585243
P20778 Human III India 1958 AF080251 Z34096
CH21955A Mosquito III Taiwan 1994 AF221500 AF221500
ML11 Vaccine III Japan 1981 AY508812 U70412
jaOArS982 Mosquito III Japan 1982 M18370 M18370
Nakayama Human III Japan 1935 EF571853 AF112297
JKT7003 Mosquito IV Indonesia 1981 U70408
Sagiyama Mosquito III Japan 1957 U70419
Kamiyama Human III Japan 1966 AB379813
K82P01 Mosquito III Japan 1982 U34926
826309 Human III India 1982 Z34094
ThCMAr6793 Mosquito I Thaliand 1993 D45363
JKT1724 Mosquito III Indonesia 1979 U70404
SH-53 Mosquito I China 2001 AY555757














Figure 1 Phylogenetic tree constructed by the neighbor-joining method, based on the polyprotein ORFs of selected Japanese
encephalitis virus strains. The CQ11-66 China 2011 human obtained in this study is shown in bold face.
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vivirus tick-borne encephalitis virus revealed that the E pro-
tein consists of three domains. The difference in the E gene
of JEV strains, particularly in domain III [8], may contribute
to the diversity of neutralizing and antigenic properties [9].
Previous research has also indicated that mutations in do-
main III modulated virus binding and entry into host cells
[10,11]. In this study, comparison of the E gene of CQ11-66
strain with the vaccine strain SA14-14-2 revealed 15 amino
acid substitutions. Among these variations, the Glu to Lys
alteration at position 138 is consistent with previous obser-
vations that the E138 mutation is associated with attenu-
ation of the JEV strain and inhibits viral spread from cell to
cell [12]. Other groups have also demonstrated that muta-
tions of residues E49, E138, E306 and E389 of the E protein
reduce the efficiency of viral binding to heparan sulphate
residues on target cells [13]. In our results, a substitution
(Met to Lys) was observed at the position E279, which may
increase virulence in mice [14].
Genetic variation among JEV strains isolated from
widely different time periods and geographical regions has
been reported in many studies [13]. A previous study
examining 46 JEV strains found that those from a much
wider geographic region and at certain time period were
similar, but that genetic variation was present among
strains from diverse regions or from different time periods
in the same region. These observations suggested JEV is
continuously evolving [15]. Meanwhile, Yun et al. [16]
reported that the E gene sequences of the 10 Korean JEVstrains, despite differences in their geographic distribu-
tions and the maximum five-year time span, showed re-
markable genetic stability. Such stability in the JEV
genome was also observed in strains from China and
Japan [17,18]. In this study, phylogenetic analyses of the
CQ11-66 ORF and the ORF of 21 other JEV strains iso-
lated from several countries revealed the lowest nucleotide
divergence and the lowest amino acid divergence with the
JaGA01 strain. Meanwhile, phylogenetic analyses of its E
gene and the E gene of 30 other JEV strains revealed the
lowest nucleotide divergence and the lowest amino acid
divergence with the JaGA01 strain.
In conclusion, we have isolated a JEV strain from a JE pa-
tient in Chongqing, China. Molecular analysis of the nucleo-
tide and amino acid sequences indicated that CQ11-66
belonged to genotype III, and comparison of the ORF se-
quence and the E gene sequence with other strains from dif-
ferent regions at different periods revealed high homology.
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Figure 2 Phylogenetic tree constructed by the neighbor-joining method, based on the envelope (E) protein gene of selected Japanese
encephalitis virus strains. The CQ11-66 China 2011 human obtained in this study is shown in bold face.
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